Advisory Board

The College of Science and Mathematics' Advisory Board provides guidance, support and advocacy for the College's pedagogical, research and outreach programs. The Board assists the College in maintaining currency with changing educational, economic, national and international needs; helps to identify emerging directions for research and educational programs, as well as sources for student support, program and research collaboration, funding and other professional opportunities; and helps to promote the College with the external community.

Barbara Brummer headshot
Dr. Barbara Brummer '68 Director, The Nature Conservancy of NJ
Elizabeth D. Kay Environment Center
Chair, Advisory Board

Dr. Barbara Brummer is the State Director at The Nature Conservancy of New Jersey where she is the key leader of the Conservancy’s program in New Jersey. A longstanding member of the Conservancy, Dr. Brummer was hired as State Director in January 2004. Prior to joining the Conservancy, she had retired from a successful career in the private sector, spending the last twelve years as an executive with Johnson & Johnson. Among her positions at J&J, she served as President of J&J Canada Inc. and Worldwide Vice President of the Women's Health and Wellness Franchise. Throughout her career Barbara has maintained a passionate interest in conservation. For many years, she taught a course in field biology at Montclair State University and has spent many hours seeking out natural areas and studying the flora of New Jersey. In addition to her longstanding membership in The Nature Conservancy, Barbara has also been active in other local conservation organizations, serving on the boards of the New Jersey Audubon Society, the Pocono Environmental Education Center and the Palisades Nature Association. Soon after joining The Nature Conservancy, she was appointed by the Commissioner of the New Jersey Department of Environmental Protection to the Endangered and Non-Game Species Advisory Committee. Barbara is active with her alma mater, serving as the Chair of the College of Science and Mathematics Advisory Board as well as on the Campaign Cabinet at Montclair State University. She has a B.A. in Biology from Montclair State University and a Ph.D. in Biological Sciences from New York University.

Michel Bitritto
Dr. Michel M. Bitritto EVP, Business Development, Retired
The EcoShelf Group

Dr. Michel M. Bitritto is a creative and accomplished science and technology business expert with over 25 years of experience in business development, marketing, R&D, entrepreneurship, management, and government. Recently retired, Michel been able to devote more time to pursuits she enjoys. She is a published author of personal, non-fiction essays and having a lot of fun with it. Additionally she provides guidance and mentorship to Montclair State students at various career skill workshops.

A high energy and results-oriented strategic thinker, Michel has been a change agent and very effective in forming productive and lasting networks to accomplish goals. Prior to retiring, Michel held a variety of leadership roles. Most recently she was Executive Vice President, Business Development at EcoShelf Group, advising science and technology clients. Before that Michel was Director, Technology & Entrepreneurship Talent Network at NJIT. Prior to that she was Director, Business Accelerator at Meadowlands Regional Business Accelerator at Bergen Community College. Michel held other positions in this field following her first career involving scientific roles as Research Manager where she supervised 50 scientists, and Global Business Director at Hoechst Celanese. Michel earned a BA in Chemistry and Math at Douglass College, an MS in Chemistry at Polytechnic Institute of Brooklyn and a PhD in Chemistry at UConn. She did Post Doc work in Polymer Chemistry at U Maryland.

Patricia Bielenberg
Dr. Patricia A. Bielenberg Fuels & Lubes, R&D Portfolio Manager
ExxonMobil Research & Eng. Co.

Dr. Paricia A. Bielenberg is currently the Fuels and Lubes R&D Portfolio Manager in ExxonMobil Research and Engineering located in Annandale, NJ. She received her BS in Chemical Engineering from the University of Notre Dame in 1999, her MS in Chemical Engineering Practice from MIT in 2002, and her PhD in Chemical Engineering from MIT in 2003. She also completed a Post-Doc at Los Alamos National Laboratory in 2005. Patty has worked for ExxonMobil for 13 years, primarily in the R&D function. She joined Intermediates Chemicals Technology in Baton Rouge, LA as a researcher. She then transferred to the Process Research labs in Annandale, NJ where she held researcher and team lead positions in a variety of catalyst and modeling research programs. She also held marketing and manufacturing assignments in the Chemicals company in Houston and Baytown, TX. For the last four years, Patty has had supervisory positions for the Active Materials section and the Novel Process Scale-up section where she was responsible for ensuring that these sections had the necessary technical capabilities for the future. Patty is involved in the community as a Girl Scout leader for her daughters’ troops. She has also participated in multiple panels at national conferences and universities on STEM careers and Women in Science and Engineering.

John Bonamo
Dr. John F. Bonamo EVP, Chief Medical and Quality Officer
RWJBarnabas Health

Dr. John F. Bonamo, Executive Vice President and Chief Medical and Quality Officer for RWJBarnabas Health, is a physician executive with a distinguished clinical background in obstetrics and gynecology and hospital leadership. Dr. Bonamo earned his M.D. degree from the University of Medicine and Dentistry of New Jersey. He completed an internship and residency in Obstetrics and Gynecology at Saint Barnabas Medical Center in 1981, and immediately joined the Medical Staff at Saint Barnabas. Dr. Bonamo is board certified by the American Board of Obstetrics and Gynecology. From 1981 through 1999, he had a busy private practice in West Orange, New Jersey and was a highly respected obstetrician and gynecologist. In January 2000, he left private practice to assume the administrative position of Senior Vice President for Medical Affairs at Saint Barnabas Medical Center. He served in that position until April 2001, at which time he was appointed President and Chief Executive Officer. Building on his experience as a physician and as an administrator, Dr. Bonamo enrolled in the Harvard School of Public Health at Harvard University, and in 2003 earned a degree of Master of Science in Health Care Management. He now serves as an adjunct lecturer in the Health Policy and Management Department in the School of Public Health, as well as a visiting Professor at the University of Beijing Masters’ Program for hospital management. Dr. Bonamo is a Fellow of the American College of Healthcare Executives, of the American Board of Obstetricians and Gynecologists, and is a member of the New Jersey Obstetrical and Gynecological Society.

Ronald Califre headshot
Mr. Ronald M. Califre '72 '08 HON SVP and Head, U.S. Operations, Retired
R&D, Novartis Pharmaceuticals Corp.
Vice Chair, Advisory Board

Mr. Ron Califre started his career with the U.S. Food and Drug Administration, where he worked for ten years in positions of increasing responsibility. He then joined Ciba-Geigy in Regulatory Affairs, eventually heading that function before being promoted to Sr. V.P., Medicine and Clinical Development, U.S. In that capacity, he was responsible for all aspects of drug development and medical and regulatory affairs, as well as heading the global neuroscience review board. At the time of the merger with Sandoz to form Novartis, Ron was appointed Sr. V.P., Drug Development. He later assumed responsibility for the discovery research functions, becoming Sr. V. P. of Research and Development, overseeing the activities of appx. 2400 people in drug discovery, pre-clinical research, early development, technical development, clinical development, drug safety, and regulatory affairs in the U.S. He was a member of the Research Management Board and the Development Leadership Team and served on the Boards of several companies and non-profit organizations. Following his retirement from Novartis, he has remained active on the advisory boards of several universities as well as engaging in independent consulting. He is a graduate of Montclair State College (B.A. ‘72) and has done graduate work in pharmacy, pharmacology and food and drug law.

Mario Carranza
Mr. Mario A. Carranza, M.H.A., FACHE Administrative Director
Atlantic Center for Research
Atlantic Health System

Mr. Mario A. Carranza, M.H.A., FACHE is the Administrative Director of the Atlantic Center for Research in the Atlantic Health System. The Atlantic Center for Research is responsible for all administrative operations and support for research throughout the Atlantic Health System. Prior to joining AHS, Mario worked as an Operations Administrator at Mayo Clinic in Florida. At Mayo Clinic he was responsible for the day to day operations of various research departments and instrumental in developing the Center for Individualized Medicine in Florida and Clinical Genomics. Mario supported various departments during his tenure at Mayo Clinic such as: Cancer Studies, Cancer Biology, Biochemistry and Molecular Biology, Neuroscience, Health Sciences, Immunology, Clinical Genomics, Comparative Medicine, Biorepository Program, Discovery & Translational Programs, Biomarker Discovery Program, Center for Individualized Medicine, Center for Regenerative Medicine, and the Center for the Science of Healthcare Delivery. He was also a member of several institutional committees such as: Research Resources Committee, Research Personnel Committee, and the Research Cores Subcommittee. Mario has also served as an adjunct professor at the University of North Florida. As the Administrative Director of the Atlantic Center for Research, he is responsible for the operations of pre-award, post-award, IRB, sponsored projects administration, research finance, research education, research quality, biostatistics, research pharmacy, clinical research and trials office, clinical research operations, and translational research. Mario believes research is a critical component to any healthcare organization that aims to bring cutting edge treatment and high quality care to its patients. He feels it is equally important to remember that there is a person at the end of the research we do, and we must respect and protect them.

Mario Casabona headshot
Mr. Mario M. Casabona Founder & Managing Partner
Casabona Ventures, LLC

Mr. Mario M. Casabona is an entrepreneur and active angel investor. In 2012, he founded TechLaunch, committed to identifying and nurturing early stage tech ventures by mentoring, coaching, and providing access to resources and capital. To date, TechLaunch has supported over 50 tech companies and mentored over 100 aspiring entrepreneurs. In 2006, he founded Casabona Ventures, investing in over 30 seed and early stage companies. In 1982, he founded Electro-Radiation Inc., which was acquired by Honeywell International in 2004. He received the Small Business Administration National Tibbett’s Award for his contributions in technology, and was listed as one of the top five most influential persons in New Jersey technology by The Star-Ledger. He was twice recognized by the New Jersey Technology Council, first as the recipient of their Legend of Technology Award and subsequently their Financier of the Year Award. Mario serves on the College of Science and Math (CSAM) Advisory Board at Montclair State University. He is Chairman Emeritus of Jumpstart NJ Angel Network and Chairman Emeritus of the R&D Council of New Jersey. He also enjoys serving on the Boards of various for-profit and non-for-profit organizations. Mr. Casabona is an electrical engineer and holds twelve national and international patents in the field of satellite-based navigation and communications.

Francis Cuss
Dr. Francis M. Cuss EVP and CSO, R&D, Retired
Bristol-Myers Squibb Company
Vice Chair, MSU Board of Trustees

Dr. Francis M. Cuss is a physician-scientist, with a background in general and academic medicine, who has developed a broad experience in pharmaceutical research, in clinical development and in executive management within globally-operating biopharma companies during a career of more than 30 years in the pharmaceutical industry, specifically with BMS, Schering-Plough and Glaxo. Francis retired from Bristol-Myers Squibb in July 2017 having served as Executive Vice President and Chief Scientific Officer since July 2013 and as a member of BMS’s Senior Management Team since 2010. He joined Bristol-Myers Squibb in 2003 and as head of Research for nearly a decade Francis led a very productive discovery organization which produced an innovative pipeline from both in-house and external programs; helping numerous patients prevail against serious disease and laying the foundation for the generation of significant company growth and value. He is a member of the board of directors of Novo Holdings A/S, Denmark, Rubius Therapeutics, Cambridge MA and Vice Chair of the Board of Trustees of Montclair State University, NJ as well as a member of the Advisory Board of the College of Science and Mathematics at the University. Prior to joining the pharmaceutical industry, Francis was a practicing physician with a specialization in pulmonary medicine in the UK. He received his education and medical training in the United Kingdom. He holds medical degrees from Cambridge University, U.K. and is a fellow of the Royal College of Physicians and the Faculty of Pharmaceutical Medicine. He has published numerous articles and book chapters on topics of medical interest.

Terernce Gunning headshot
Mr. Terence J. Gunning '79 President
Lone Oak Business Solution

Mr. Terence J. Gunning is currently Chief Executive Officer of Lone Oak Business Solutions, a life sciences consulting firm. Terry has 30 years of management experience in the healthcare industry including diagnostic testing and services, medical devices and consumer healthcare products. Prior to Lone Oak Business Solutions, Terry was CEO of Cadent, a worldwide medical service and device start-up headquartered in Carlstadt, New Jersey. Terry’s tenure as Cadent’s CEO brought a tripling of revenue and significant improvement in operating profit and cash flow concurrent with several successful capital funding campaigns which paved the way for a successful strategic exit. As President of Datascope’s Cardiac Assist Division (CA) Terry brought significant sales increases, the launch of three new products, CA’s first successful acquisition and re-establishment of CA as the worldwide leader in counter-pulsation therapy. As Vice President and Head of the Corporate Anatomic Pathology Division, and as Vice President, Marketing, for Quest Diagnostics, he led several growth initiatives resulting in significant top- and bottom-line improvements. His resume includes marketing-related senior management positions with Johnson & Johnson Consumer Products and Bristol-Myers Squibb. Terry earned his MBA - Finance and Accounting at Columbia University and BS in Chemistry at Montclair State University. Terry and his wife Kathy are married 28 years and are the proud parents of four children. They reside in Basking Ridge, NJ.

Merwin Kinkade
Mr. Merwin Kinkade, CHMM, REM '80 MA Founder and Vice President
Viridian Environmental

Mr. Merwin Kinkade established Viridian® Inc. Environmental Consultants in 1991 to provide services to lending institutions, realtors, attorneys, municipalities, and commercial and industrial clients. The firm was incorporated in New Jersey in 1992. His areas of expertise include environmental site assessments (Transaction Screens, Phases I, II, and III), Preliminary Assessments, Site Investigations, Remedial Investigations, Remedial Action Workplans and Remedial Action Reports, underground storage tanks, Industrial Site Recovery Act (ISRA) investigation and remediation, hazardous materials assessments, site plan review for Planning and Zoning Boards, and municipal environmental consulting. Before forming Viridian, Kinkade was a principal and environmental group director for a mid-size engineering consulting firm, and regional manager for a national environmental contractor. He was on the adjunct faculty at NJ Institute of Technology from 1970 until 1993, teaching courses related to ecology, environment, energy, and technology. Mr. Kinkade has attained various certifications and trainings, and served on a number of planning boards, environmental commissions and non-profit boards in leadership roles. Mr. Kinkade earned a BS in Business Administration at Babson College, an MA In Personnel Administration at NYU and an MA in Environmental Studies at Montclair State University.

Mark Koehne headshot
Mr. Mark Koehne SVP and Actuary
Mutual of America Life Insurance Company

Mr. Mark Koehne is the Senior Vice President and Actuary for Mutual of America’s Actuarial Consulting Services Department. Since 2003, he has been responsible for leading the 23 member Actuarial Consulting Services Department, which provides actuarial valuations and other services required for the ongoing funding and administration of defined benefit plans sponsored by over 125 clients. The department also provide design and compliance services to defined contribution type plans. Mr. Koehne has over 40 years of experience in the valuation and design of defined benefit and defined contribution plans and has spent over 30 years working specifically with plans of not-for-profit employers, including multiple employer plans. Most recently, he has spearheaded the company’s successful re-entry into the pension risk transfer space. Mr. Koehne began his career with Mutual of America in 1975. Prior to rejoining the firm in 1996, Mr. Koehne was employed as a Vice President with Alexander & Alexander for 10 years during which time he worked with a number of Fortune 500 clients and other nationally recognized firms. He graduated from the College of Insurance with a Bachelor of Science degree in Actuarial Sciences. Mr. Koehne is an Enrolled Actuary and a member of the American Academy of Actuaries. He is a member of the Pension Board for the Archdiocese of Newark, where he also chairs the Investment Committee, the Pension Board of the Diocese of Metuchen, and the New York State Actuarial Advisory Committee.

Anthony Matarazzo headshot
Mr. Anthony J. Matarazzo '94 MS Senior Director, Water Quality and Environmental Management
New Jersey American Water

Mr. Anthony Matarazzo is the Senior Director, Water Quality and Environmental Management at New Jersey American Water, and has been a leader at the company since 2003. He has been actively involved in collaborations with various faculty at Montclair State including the Passaic River Institute and is passionate about providing career-building jobs opportunities for the next generation of science students. Anthony currently has one of CSAM’s own Green Team students on his staff who is graduating next year with a BS/MS in Environmental Studies. Anthony is a proud alumnus of Montclair State University where he earned his M.S in Environmental Management in 1994. Prior to that he earned a Bachelor’s degree at Rutgers, majoring in Biology and Chemistry. He enjoys travel and is an avid fisherman.

Marc Morresi
Dr. Marc Morresi '99 Internist
Summit Medical Group

Dr. Marc Morresi is an Internist at Summit Medical Group. He brings a wealth of experiences to a practice in Bloomfield, the town where he grew up, along with a lifelong ambition to be caring, compassionate physician. Prior to joining SMG in 2016, Marc developed and ran Morresi Medical Associates from 2011.

He attended Seton Hall Prep for high school and on to NJIT for college. However, following a first-hand experience during a student tour at MSU, he knew that was the place for him, transferred and ultimately graduated from Montclair with a degree in Biology in 1999. Marc earned his M.D. degree from Saba University School of Medicine in Netherlands-Antilles in 2005, began his residency in Internal Medicine at UMDNJ-NJ and graduated from residency in 2010 after accepting a Chief Resident Position at Hackensack University Medical Center from 2009-2010. Marc has been a physician at Hackensack University Medical Center and Hackensack Meridian Mountainside Hospital. Marc has served on several committees at Mountainside Hospital including the Credentialing Committee and as a current member of the Board of Trustees for the last five years.

Linda Obenaur-Kutner
Ms. Linda J. Obenauer-Kutner '80 '83 MA Senior Research Scientist II
Pharmaceutical Development
Bristol-Myers Squibb Company

Ms. Linda J. Obenauer-Kutner is a Scientist and a cancer survivor, Linda is a passionate supporter of science advocacy and giving back to the community. Linda has been a Pharmaceutical industry professional for over 25 years. As an analytical CMC lead at Bristol-Myers Squibb, she has been a significant contributor to the initial filing of Opdivo, an Immuno-Oncology treatment for different cancer types. She continues contributing towards formulation development in a senior research scientist role in R&D. She joined BMS in 2006 from Schering-Plough Research Institute (currently Merck). Linda supports outreach efforts through her association with organizations like Association for Women in Science (AWIS) and is a core team member of the BMS Adoption Community Network (ACN). As the treasurer at AWIS New Jersey, a multi-disciplinary organization for women in science, technology, engineering and mathematics (STEM), she volunteers her time to support initiatives to promote policies that increase women representation and leadership positions by fostering a positive public image of women in STEM. Linda holds a Bachelor of Science and Master of Arts degree in Biology from Montclair State University. She has numerous publications in peer-reviewed journals.

Meme Omagbai
Ms. Meme Omogbai President & CEO
Meme Omogbai & Associates

Ms. Meme Omogbai is named one of 25 Influential Black Women in Business by The Network Journal in 2010, Ms. Omogbai has been a leader in the nonprofit, corporate, museum and government sectors. As the first American of African descent named Board Chair of the American Alliance of Museums (AAM), Ms. Omogbai co-authored its ground-breaking strategic plan, The Spark, and led the initiative to rebrand the AAM as a global alliance. As Co-Director, Interim CEO, COO, CFO and Trustee, she led a major transformation in operating performance at the 105-year-old Newark Museum. Her program of financial accountability and innovation propelled the organization to the pinnacle of achievement with four consecutive years of 4-star Guide Star ratings for superior management. Ms. Omogbai’s background includes serving as the first minority (and youngest) Deputy Assistant Chancellor of New Jersey’s Department of Higher Education. Her multifaceted earlier experience includes expertise in finance and management with the New Jersey Casino Control Commission, former Big 8 Global Accounting Firm Arthur Young & Co. She currently serves as a Director on the boards of the AAM, The Advisory Board of Montclair State University’s College of Science & Mathematics, and St. Vincent Academy. She has also been appointed by the Emir of Borgu Kingdom and Emirate to the Think Tank on the cultural infrastructure of the Emirate and establishment of its monuments and history. She is the Immediate Past Chair of New Jersey Historic Trust, after previously serving two years as Chair and two as Vice Chair.

Robert Pollock
Mr. Robert Pollock Sr. Director Environmental Projects and Permitting
Public Service Electric and Gas Company (PSE&G)

Mr. Pollock brings biological and regulatory permitting, as well as, management experience acquired within the utility, private development and public sectors. He served as the owner of Environmental Resource Consulting, LLC for 7 years upon which a utility focus was developed in identifying environmental regulatory requirements and ultimately delivering agency approvals. Currently, as Sr. Director – Environmental Projects and Permitting at Public Service and Electric Gas Company he directs a group of 23 associates responsible for preparing and implementing high level strategies necessary for obtaining regulatory approvals for approximately $2 billion in capital infrastructure projects annually.

Richard Russo
Mr. Richard Russo President and CEO
Endomedix, Inc.

Mr. Richard Russo is a 30+ year Medtech veteran. He is currently CEO of Endomedix Inc., a start-up working with biopolymer chemistry to develop a hemostat for use in brain surgery. Prior to Endomedix, he was the CEO of a start-up that became the largest processor in Europe of human tissue for transplantation, OST Développement in Clermont-Ferrand, France. OST serviced customers throughout Europe, Latin America and Asia. He had previously helped successfully develop and commercialize devices using pulsed electromagnetic field and ultrasound technologies to stimulate bone formation. Functionally, he has worked in sales and marketing, clinical research, regulatory affairs and strategic planning, in addition to general management. Richard earned a BA cum laude in philosophy from Boston College before pursuing graduate studies in philosophy at the Université de Fribourg in Switzerland. Richard also earned an MBA from Columbia Business School in NYC.

Ni'Kita Wilson
Ms. Ni'Kita Wilson '99 Vice President, Sales and Innovation
Aware Products

Ms. Ni’Kita Wilson is an award winning cosmetic chemistry expert who holds numerous patents, has authored chapters of books, speaks at industry conferences around the country, and developed a number of skincare lines. Essence magazine recognized Ni’Kita as one of the premier Cosmetic Chemists in the beauty industry and featured her in the May 2013 issue of the magazine and on Ni’Kita is Vice President of Sales and Innovation at Aware Products. Prior to that she was Founder and CEO of Skinects LLC and Catalyst Cosmetic Development. Earlier positions included leadership roles in cosmetic labs. In her current role, Ni’Kita enjoys the unique position on both the creative and consumer sides of the beauty business. On the business end, she can act as a liaison between marketing and R&D to facilitate product launches or a partner to R&D to handle creative "overload" (too many projects but not enough time or staff). For the consumer she offers insight on beauty products, answers questions about ingredients and debunks myths, new and old, that continually plague the industry. Ni'Kita is a member of the New York Chapter- Society of Cosmetic Chemists (SCC), an active member of Cosmetic Executive Women (CEW) and Fashion Group International.